One study on breast carcinomas, melanoma, and colon cancer tissues, where the majority of TINK cells belonged to the CD56brightCD16dim subset, demonstrated high expression of dNK cell markers CD9 and CXCR3 in the breast and colon tumors [11]. This evidence concerns the gene CD9 and colonic neoplasm.